Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimating the global burden of Epstein–Barr virus-related cancers
Yide Wong, Michael T. Meehan, Scott R. Burrows, et al.
Journal of Cancer Research and Clinical Oncology (2021) Vol. 148, Iss. 1, pp. 31-46
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Epstein–Barr virus and multiple sclerosis
Samantha S. Soldan, Paul M. Lieberman
Nature Reviews Microbiology (2022) Vol. 21, Iss. 1, pp. 51-64
Open Access | Times Cited: 299
CD4+ T cells in cancer
Daniel E. Speiser, Obinna Chijioke, Karin Schaeuble, et al.
Nature Cancer (2023) Vol. 4, Iss. 3, pp. 317-329
Closed Access | Times Cited: 252
The role of Epstein–Barr virus in nasopharyngeal carcinoma
Zhi Yi Su, Pui Yan Siak, Chee‐Onn Leong, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 62
mRNA vaccines: The future of prevention of viral infections?
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 52
Epstein-Barr virus: the mastermind of immune chaos
Jean de Melo Silva, Carlos Eduardo de Castro Alves, Gemilson Soares Pontes
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
The Role of Chronic Inflammation in Pediatric Cancer
Christine Mella, Panogiotis Tsarouhas, Maximillian Brockwell, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 154-154
Open Access | Times Cited: 3
USP7 Inhibitors Destabilize EBNA1 and Suppress Epstein‐Barr Virus Tumorigenesis
Christopher Chen, Kush Addepalli, Samantha S. Soldan, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access | Times Cited: 2
Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub-National-Level Estimates and Future Projections
Gulfaraz Khan, Muhammad Jawad Hashim
Journal of Epidemiology and Global Health (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
EBV-associated diseases: Current therapeutics and emerging technologies
Srishti Chakravorty, Behdad Afzali, Majid Kazemian
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52
KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine
Corey Casper, Lawrence Corey, Jeffrey I. Cohen, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 45
EBV and Lymphomagenesis
Daniel Sausen, Ayeman Basith, Syed Muqeemuddin
Cancers (2023) Vol. 15, Iss. 7, pp. 2133-2133
Open Access | Times Cited: 27
Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers
Atharva S. Torne, Erle S. Robertson
Cancers (2024) Vol. 16, Iss. 5, pp. 991-991
Open Access | Times Cited: 12
Characteristics and Clinical Significance of Gut Microbiota in Patients With Epstein‐Barr Virus‐Associated Liver Dysfunction
Zhan Yi, Yu Fu, Hanchuan Dai, et al.
Microbiology and Immunology (2025)
Closed Access | Times Cited: 1
Multiple sclerosis and infection: history, EBV, and the search for mechanism
Elliott D. SoRelle, Micah A. Luftig
Microbiology and Molecular Biology Reviews (2025)
Closed Access | Times Cited: 1
CircRNA-miRNA-VEGFA: an important pathway to regulate cancer pathogenesis
Lei Zhang, Yuan Zhang, Xin Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study
Bradley M. Haverkos, Önder Alpdoğan, Robert A. Baiocchi, et al.
Blood Advances (2023) Vol. 7, Iss. 20, pp. 6339-6350
Open Access | Times Cited: 19
Oncogenic Viruses and the Epigenome: How Viruses Hijack Epigenetic Mechanisms to Drive Cancer
Signe MacLennan, Marco A. Marra
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9543-9543
Open Access | Times Cited: 18
Treatment of Epstein-Barr Virus infection in immunocompromised patients
Martyna Pociupany, Robert Snoeck, Daan Dierickx, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116270-116270
Closed Access | Times Cited: 8
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection
L. Zhong, Wanlin Zhang, Hong Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Hypoxia-induced ebv-circLMP2A promotes angiogenesis in EBV-associated gastric carcinoma through the KHSRP/VHL/HIF1α/VEGFA pathway
Yu Du, Jing‐yue Zhang, Li‐ping Gong, et al.
Cancer Letters (2021) Vol. 526, pp. 259-272
Closed Access | Times Cited: 40
Burkitt Lymphoma Incidence in Five Continents
Sam M. Mbulaiteye, Susan S. Devesa
Hemato (2022) Vol. 3, Iss. 3, pp. 434-453
Open Access | Times Cited: 26
HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD
Hannes Vietzen, Philippe L. Furlano, Jan J. Cornelissen, et al.
Blood (2022) Vol. 141, Iss. 13, pp. 1560-1573
Open Access | Times Cited: 25
Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma
Ying Liao, Jiangbo Zhang, Lixia Lu, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Increased Prevalence of EBV Infection in Nasopharyngeal Carcinoma Patients: A Six-Year Cross-Sectional Study
Abdullah E. Al-Anazi, Bader S. Alanazi, Huda M. Alshanbari, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 643-643
Open Access | Times Cited: 15
Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis
Corey Smith, Rajiv Khanna
Clinical & Translational Immunology (2023) Vol. 12, Iss. 3
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top